Hatfield, Hertfordshireshire, United Kingdom Crohn's & Colitis Foundation of America is the famous Corporate Investor, which was founded in 1967.
The high activity for fund was in 2018. The fund is generally included in less than 2 deals every year.
Among the various public portfolio startups of the fund, we may underline Vedanta Biosciences Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most successful fund investment fields, there are Medical, Business Development.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the Crohn's & Colitis Foundation of America, startups are often financed by Rock Springs Capital, PureTech Health, Invesco. In the next rounds fund is usually obtained by Partners Investment, Symbiosis Group, Symbiosis.
Related Funds
| Fund Name | Location |
| Adtalem Global Education | Downers Grove, Illinois, United States |
| C.Domain Capital | Beijing, Beijing, China |
| Daiwa SMBC Capital | Japan, Tokyo |
| Edu-Capital | Beijing, Beijing, China |
| Fame Mount Limited | - |
| Fuhai Yintao | China, Guangdong, Shenzhen |
| FUJIFILM | Chiyoda, Japan |
| Hull Street Capital | Bethesda, Maryland, United States |
| Jiaxing Pucheng Gquan Touzi Hehuoqiye | China, Jiaxing, Zhejiang |
| Kingson Capital Partners | Durban, KwaZulu-Natal, South Africa |
| New Frontier Renewable Energy | - |
| Norwegian Research Council | Norway, Oslo |
| Polaris Private Equity | Copenhagen, Denmark, Hovedstaden |
| Shefa Capital | Israel, Tel Aviv, Tel Aviv District |
| Silverblue | - |
| TechMinsk | Belarus, Minsk |
| Ten Innovate | - |
| Tengda Touzi | - |
| Valquest Partners | Beirut, Beyrouth, Lebanon |
| Viva BioInnovator | China, Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 